Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
IBA-Radcal

Download Mobile App




Radiation Risk Predicted for Astronauts on Space Station

By MedImaging staff writers
Posted on 25 Feb 2008
An accurate method predicts the doses of radiation that astronauts will receive aboard the orbiting European laboratory module, Columbus, recently attached to the International Space Station (ISS).

The radiation environment close to Earth consists mainly of particles trapped in the Earth's magnetic field, particles that arrive from deep space called Galactic Cosmic Rays (GCRs), and particles expelled from the Sun during solar eruptions. More...
These components vary with time, mainly due to the unpredictable activity of the Sun, which influences the Earth's magnetic field. In turn, the Earth's field determines the extent of the trapped particles and how well Earth is shielded from incoming GCRs.

Beyond the Earth's magnetic field, spacecraft and their occupants are exposed to the full force of the GCRs and the solar eruptions. Missions to the Moon and Mars venture into this harsher and unpredictable radiation environment for periods of many months or even years.

A new software package accurately simulates the physics of radiation particles passing through spacecraft walls and human bodies. Such techniques will be essential to use for calculating the radiation doses received by astronauts on future voyages to the Moon and Mars.

The project, funded by European Space Agency's (ESA; Paris, France; www.esa.int) General Studies Program and the Swedish National Space Board (SNSB; Solna, Sweden), was initiated by Christer Fuglesang of ESA's European Astronaut Corps. The ESA simulation is called Dose Estimation by Simulation of the International Space Station (ISS) Radiation Environment (DESIRE). "The project was designed to provide a European capability in accurately predicting radiation doses onboard Columbus,” stated Petteri Nieminen, ESA's technical officer on the study.

To predict accurately the radiation risk faced by astronauts, scientists and engineers must tackle three separate problems: How much radiation is hitting the space vehicle? How much of that radiation is blocked by the available shielding? What are the biologic effects of the radiation on the astronauts?

To provide the environmental information, ESA is flying a standard radiation monitor on a number of its spacecraft, including Proba-1, Integral, Rosetta, GIOVE-B, Herschel, and Planck. Known as the Standard Radiation Environment Monitor (SREM), it measures high-energy radiation particles. It was developed and manufactured by Oerlikon Space (Zurich, Switzerland) in cooperation with Paul Scherrer Institute Villigen PSI, Switzerland) under a development contract from ESA.


Related Links:
European Space Agency
Oerlikon Space
Paul Scherrer Institute

Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Floor‑Mounted Digital X‑Ray System
MasteRad MX30+
Hemostatic Agent
HEMOBLAST Bellows
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: The AI-based approach identifies lipid regions matched well with histopathology results (Photo courtesy of Hyeong Soo Nam/KAIST)

AI-Based OCT Image Analysis Identifies High-Risk Plaques in Coronary Arteries

Lipid-rich plaques inside coronary arteries are strongly associated with heart attacks and other major cardiac events. While optical coherence tomography (OCT) provides detailed images of vessel structure... Read more

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.